UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Woodward Diversified Capital LLC

Woodward Diversified Capital LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 39.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 833 shares of the healthcare conglomerate’s stock after selling 549 shares during the period. Woodward Diversified Capital LLC’s holdings in UnitedHealth Group were worth $421,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group during the third quarter valued at about $27,000. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth approximately $30,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at approximately $37,000. Friedenthal Financial bought a new stake in shares of UnitedHealth Group in the third quarter worth $51,000. Finally, Highline Wealth Partners LLC acquired a new position in UnitedHealth Group during the 3rd quarter worth $55,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.6 %

Shares of NYSE:UNH opened at $526.68 on Friday. The firm has a market cap of $484.69 billion, a P/E ratio of 33.98, a P/E/G ratio of 1.45 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a 50 day moving average of $530.85 and a 200-day moving average of $564.52.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the firm posted $5.83 earnings per share. The company’s revenue was up 6.8% on a year-over-year basis. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently commented on UNH. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Barclays lowered their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. KeyCorp reiterated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. TD Cowen lifted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $629.32.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.